In a transformative study published in the journal Science Translational Medicine, an international team of researchers has made a significant breakthrough in the understanding and potential treatment of multiple sclerosis ...
Apr 4, 2024
0
115
Levels of dopamine and the placebo effect can determine whether patients with social anxieties improve when treated with SSRIs. A new study shows the effect was four times higher for patients with high expectations of the ...
Nov 8, 2021
0
158
Clonal hematopoiesis is a biological process in which a blood stem cell (the population that gives rise to a variety of blood cell types) acquires an advantageous mutation and outgrows neighboring cells. Clonal hematopoiesis ...
Aug 2, 2022
0
23
A three-factor, composite clinical severity staging system can optimize treatment selection for the management of Meniere disease, according to a study published online Aug. 25 in Otolaryngology—Head and Neck Surgery.
Sep 6, 2023
0
1
Medicare costs for older patients with oral cavity and pharyngeal cancers increased based on demographics, co-existing illnesses and treatment selection, according to a report published online by JAMA Otolaryngology-Head ...
Jun 4, 2015
0
10
Characterized by pathological weight loss driven by restrictive feeding and excessive exercise behaviors, anorexia nervosa (AN) has one of the highest mortality rates of any psychiatric disease.
May 13, 2024
0
114
A functional precision medicine study conducted in Finland demonstrates that treatment selection based on results from drug sensitivity testing of patients' cells can be clinically useful in patients with aggressive hematological ...
Nov 17, 2021
0
1
(HealthDay)—Brisdelle (paroxetine) has been approved by the U.S. Food and Drug Administration as the first non-hormonal treatment to treat hot flashes associated with menopause.
Jul 1, 2013
0
0
The production of new neurons in the adult normal cortex in response to the antidepressant, fluoxetine, is reported in a study published online this week in Neuropsychopharmacology.
Jan 4, 2013
0
0
Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial ...
May 8, 2013
0
0
